▶ 調査レポート

世界の細胞治療バイオプロセシング市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Cell Therapy Bioprocessing Market 2021 by Company, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界の細胞治療バイオプロセシング市場 2021:企業別、地域別、種類・用途別 / Global Cell Therapy Bioprocessing Market 2021 by Company, Regions, Type and Application, Forecast to 2026 / GIR-107A12149資料のイメージです。• レポートコード:GIR-107A12149
• 出版社/出版日:GlobalInfoResearch / 2021年7月
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、86ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、細胞治療バイオプロセシングのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。細胞治療バイオプロセシングの種類別市場規模(免疫細胞、ヒト胚性幹細胞、多能性幹細胞幹細胞、造血幹細胞)、用途別市場規模(心血管疾患(CVD)、腫瘍学、創傷治癒、整形外科、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・細胞治療バイオプロセシングの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Fresenius Medical Care、Omnica Corporation、Medtronic、Baxter International、B. Braun、Nikkiso、Asahi Kasei Medical、Infomed、Bellco
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:免疫細胞、ヒト胚性幹細胞、多能性幹細胞幹細胞、造血幹細胞
・用途別分析2016年-2026年:心血管疾患(CVD)、腫瘍学、創傷治癒、整形外科、その他
・細胞治療バイオプロセシングの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・細胞治療バイオプロセシングのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・細胞治療バイオプロセシングのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・細胞治療バイオプロセシングの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・細胞治療バイオプロセシングの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Cell Therapy Bioprocessing market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Cell Therapy Bioprocessing size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Cell Therapy Bioprocessing market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Cell Therapy Bioprocessing market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Immune Cell
Human Embryonic Stem Cells
Pluripotent Stem Cells Stem Cell
Hematopoetic Stem Cells

Market segment by Application, can be divided into
Cardiovascular Disease (CVD)
Oncology
Wound Healing
Orthopedic
Others

Market segment by players, this report covers
Fresenius Medical Care
Omnica Corporation
Medtronic
Baxter International
B. Braun
Nikkiso
Asahi Kasei Medical
Infomed
Bellco

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Cell Therapy Bioprocessing product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Cell Therapy Bioprocessing, with revenue, gross margin and global market share of Cell Therapy Bioprocessing from 2019 to 2021.
Chapter 3, the Cell Therapy Bioprocessing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Cell Therapy Bioprocessing market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Cell Therapy Bioprocessing research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Product Overview and Scope of Cell Therapy Bioprocessing
1.2 Classification of Cell Therapy Bioprocessing by Type
1.2.1 Overview: Global Cell Therapy Bioprocessing Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Cell Therapy Bioprocessing Revenue Market Share by Type in 2020
1.2.3 Immune Cell
1.2.4 Human Embryonic Stem Cells
1.2.5 Pluripotent Stem Cells Stem Cell
1.2.6 Hematopoetic Stem Cells
1.3 Global Cell Therapy Bioprocessing Market by Application
1.3.1 Overview: Global Cell Therapy Bioprocessing Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Cardiovascular Disease (CVD)
1.3.3 Oncology
1.3.4 Wound Healing
1.3.5 Orthopedic
1.3.6 Others
1.4 Global Cell Therapy Bioprocessing Market Size & Forecast
1.5 Global Cell Therapy Bioprocessing Market Size and Forecast by Region
1.5.1 Global Cell Therapy Bioprocessing Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Cell Therapy Bioprocessing Market Size by Region, (2016-2021)
1.5.3 North America Cell Therapy Bioprocessing Market Size and Prospect (2016-2026)
1.5.4 Europe Cell Therapy Bioprocessing Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Cell Therapy Bioprocessing Market Size and Prospect (2016-2026)
1.5.6 South America Cell Therapy Bioprocessing Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Cell Therapy Bioprocessing Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Cell Therapy Bioprocessing Market Drivers
1.6.2 Cell Therapy Bioprocessing Market Restraints
1.6.3 Cell Therapy Bioprocessing Trends Analysis
2 Company Profiles
2.1 Fresenius Medical Care
2.1.1 Fresenius Medical Care Details
2.1.2 Fresenius Medical Care Major Business
2.1.3 Fresenius Medical Care Cell Therapy Bioprocessing Product and Solutions
2.1.4 Fresenius Medical Care Cell Therapy Bioprocessing Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Fresenius Medical Care Recent Developments and Future Plans
2.2 Omnica Corporation
2.2.1 Omnica Corporation Details
2.2.2 Omnica Corporation Major Business
2.2.3 Omnica Corporation Cell Therapy Bioprocessing Product and Solutions
2.2.4 Omnica Corporation Cell Therapy Bioprocessing Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Omnica Corporation Recent Developments and Future Plans
2.3 Medtronic
2.3.1 Medtronic Details
2.3.2 Medtronic Major Business
2.3.3 Medtronic Cell Therapy Bioprocessing Product and Solutions
2.3.4 Medtronic Cell Therapy Bioprocessing Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Medtronic Recent Developments and Future Plans
2.4 Baxter International
2.4.1 Baxter International Details
2.4.2 Baxter International Major Business
2.4.3 Baxter International Cell Therapy Bioprocessing Product and Solutions
2.4.4 Baxter International Cell Therapy Bioprocessing Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Baxter International Recent Developments and Future Plans
2.5 B. Braun
2.5.1 B. Braun Details
2.5.2 B. Braun Major Business
2.5.3 B. Braun Cell Therapy Bioprocessing Product and Solutions
2.5.4 B. Braun Cell Therapy Bioprocessing Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 B. Braun Recent Developments and Future Plans
2.6 Nikkiso
2.6.1 Nikkiso Details
2.6.2 Nikkiso Major Business
2.6.3 Nikkiso Cell Therapy Bioprocessing Product and Solutions
2.6.4 Nikkiso Cell Therapy Bioprocessing Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 Nikkiso Recent Developments and Future Plans
2.7 Asahi Kasei Medical
2.7.1 Asahi Kasei Medical Details
2.7.2 Asahi Kasei Medical Major Business
2.7.3 Asahi Kasei Medical Cell Therapy Bioprocessing Product and Solutions
2.7.4 Asahi Kasei Medical Cell Therapy Bioprocessing Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Asahi Kasei Medical Recent Developments and Future Plans
2.8 Infomed
2.8.1 Infomed Details
2.8.2 Infomed Major Business
2.8.3 Infomed Cell Therapy Bioprocessing Product and Solutions
2.8.4 Infomed Cell Therapy Bioprocessing Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 Infomed Recent Developments and Future Plans
2.9 Bellco
2.9.1 Bellco Details
2.9.2 Bellco Major Business
2.9.3 Bellco Cell Therapy Bioprocessing Product and Solutions
2.9.4 Bellco Cell Therapy Bioprocessing Revenue, Gross Margin and Market Share (2019-2021)
2.9.5 Bellco Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Cell Therapy Bioprocessing Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Cell Therapy Bioprocessing Players Market Share
3.2.2 Top 10 Cell Therapy Bioprocessing Players Market Share
3.2.3 Market Competition Trend
3.3 Cell Therapy Bioprocessing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Cell Therapy Bioprocessing Revenue and Market Share by Type (2016-2021)
4.2 Global Cell Therapy Bioprocessing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Cell Therapy Bioprocessing Revenue Market Share by Application (2016-2021)
5.2 Cell Therapy Bioprocessing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Cell Therapy Bioprocessing Revenue by Type (2016-2026)
6.2 North America Cell Therapy Bioprocessing Revenue by Application (2016-2026)
6.3 North America Cell Therapy Bioprocessing Market Size by Country
6.3.1 North America Cell Therapy Bioprocessing Revenue by Country (2016-2026)
6.3.2 United States Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
6.3.3 Canada Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
6.3.4 Mexico Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Cell Therapy Bioprocessing Revenue by Type (2016-2026)
7.2 Europe Cell Therapy Bioprocessing Revenue by Application (2016-2026)
7.3 Europe Cell Therapy Bioprocessing Market Size by Country
7.3.1 Europe Cell Therapy Bioprocessing Revenue by Country (2016-2026)
7.3.2 Germany Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
7.3.3 France Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
7.3.5 Russia Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
7.3.6 Italy Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Cell Therapy Bioprocessing Revenue by Type (2016-2026)
8.2 Asia-Pacific Cell Therapy Bioprocessing Revenue by Application (2016-2026)
8.3 Asia-Pacific Cell Therapy Bioprocessing Market Size by Region
8.3.1 Asia-Pacific Cell Therapy Bioprocessing Revenue by Region (2016-2026)
8.3.2 China Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
8.3.3 Japan Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
8.3.4 South Korea Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
8.3.5 India Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
8.3.7 Australia Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Cell Therapy Bioprocessing Revenue by Type (2016-2026)
9.2 South America Cell Therapy Bioprocessing Revenue by Application (2016-2026)
9.3 South America Cell Therapy Bioprocessing Market Size by Country
9.3.1 South America Cell Therapy Bioprocessing Revenue by Country (2016-2026)
9.3.2 Brazil Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
9.3.3 Argentina Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Cell Therapy Bioprocessing Revenue by Type (2016-2026)
10.2 Middle East & Africa Cell Therapy Bioprocessing Revenue by Application (2016-2026)
10.3 Middle East & Africa Cell Therapy Bioprocessing Market Size by Country
10.3.1 Middle East & Africa Cell Therapy Bioprocessing Revenue by Country (2016-2026)
10.3.2 Turkey Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
10.3.4 UAE Cell Therapy Bioprocessing Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Cell Therapy Bioprocessing Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Cell Therapy Bioprocessing Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Cell Therapy Bioprocessing Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Cell Therapy Bioprocessing Revenue (USD Million) by Region (2016-2021)
Table 5. Global Cell Therapy Bioprocessing Revenue Market Share by Region (2021-2026)
Table 6. Fresenius Medical Care Corporate Information, Head Office, and Major Competitors
Table 7. Fresenius Medical Care Major Business
Table 8. Fresenius Medical Care Cell Therapy Bioprocessing Product and Solutions
Table 9. Fresenius Medical Care Cell Therapy Bioprocessing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Omnica Corporation Corporate Information, Head Office, and Major Competitors
Table 11. Omnica Corporation Major Business
Table 12. Omnica Corporation Cell Therapy Bioprocessing Product and Solutions
Table 13. Omnica Corporation Cell Therapy Bioprocessing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Medtronic Corporate Information, Head Office, and Major Competitors
Table 15. Medtronic Major Business
Table 16. Medtronic Cell Therapy Bioprocessing Product and Solutions
Table 17. Medtronic Cell Therapy Bioprocessing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Baxter International Corporate Information, Head Office, and Major Competitors
Table 19. Baxter International Major Business
Table 20. Baxter International Cell Therapy Bioprocessing Product and Solutions
Table 21. Baxter International Cell Therapy Bioprocessing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. B. Braun Corporate Information, Head Office, and Major Competitors
Table 23. B. Braun Major Business
Table 24. B. Braun Cell Therapy Bioprocessing Product and Solutions
Table 25. B. Braun Cell Therapy Bioprocessing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. Nikkiso Corporate Information, Head Office, and Major Competitors
Table 27. Nikkiso Major Business
Table 28. Nikkiso Cell Therapy Bioprocessing Product and Solutions
Table 29. Nikkiso Cell Therapy Bioprocessing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Asahi Kasei Medical Corporate Information, Head Office, and Major Competitors
Table 31. Asahi Kasei Medical Major Business
Table 32. Asahi Kasei Medical Cell Therapy Bioprocessing Product and Solutions
Table 33. Asahi Kasei Medical Cell Therapy Bioprocessing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. Infomed Corporate Information, Head Office, and Major Competitors
Table 35. Infomed Major Business
Table 36. Infomed Cell Therapy Bioprocessing Product and Solutions
Table 37. Infomed Cell Therapy Bioprocessing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Bellco Corporate Information, Head Office, and Major Competitors
Table 39. Bellco Major Business
Table 40. Bellco Cell Therapy Bioprocessing Product and Solutions
Table 41. Bellco Cell Therapy Bioprocessing Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 42. Global Cell Therapy Bioprocessing Revenue (USD Million) by Players (2019-2021)
Table 43. Global Cell Therapy Bioprocessing Revenue Share by Players (2019-2021)
Table 44. Breakdown of Cell Therapy Bioprocessing by Company Type (Tier 1, Tier 2 and Tier 3)
Table 45. Cell Therapy Bioprocessing Players Head Office, Products and Services Provided
Table 46. Cell Therapy Bioprocessing Mergers & Acquisitions in the Past Five Years
Table 47. Cell Therapy Bioprocessing New Entrants and Expansion Plans
Table 48. Global Cell Therapy Bioprocessing Revenue (USD Million) by Type (2016-2021)
Table 49. Global Cell Therapy Bioprocessing Revenue Share by Type (2016-2021)
Table 50. Global Cell Therapy Bioprocessing Revenue Forecast by Type (2021-2026)
Table 51. Global Cell Therapy Bioprocessing Revenue by Application (2016-2021)
Table 52. Global Cell Therapy Bioprocessing Revenue Forecast by Application (2021-2026)
Table 53. North America Cell Therapy Bioprocessing Revenue by Type (2016-2021) & (USD Million)
Table 54. North America Cell Therapy Bioprocessing Revenue by Type (2021-2026) & (USD Million)
Table 55. North America Cell Therapy Bioprocessing Revenue by Application (2016-2021) & (USD Million)
Table 56. North America Cell Therapy Bioprocessing Revenue by Application (2021-2026) & (USD Million)
Table 57. North America Cell Therapy Bioprocessing Revenue by Country (2016-2021) & (USD Million)
Table 58. North America Cell Therapy Bioprocessing Revenue by Country (2021-2026) & (USD Million)
Table 59. Europe Cell Therapy Bioprocessing Revenue by Type (2016-2021) & (USD Million)
Table 60. Europe Cell Therapy Bioprocessing Revenue by Type (2021-2026) & (USD Million)
Table 61. Europe Cell Therapy Bioprocessing Revenue by Application (2016-2021) & (USD Million)
Table 62. Europe Cell Therapy Bioprocessing Revenue by Application (2021-2026) & (USD Million)
Table 63. Europe Cell Therapy Bioprocessing Revenue by Country (2016-2021) & (USD Million)
Table 64. Europe Cell Therapy Bioprocessing Revenue by Country (2021-2026) & (USD Million)
Table 65. Asia-Pacific Cell Therapy Bioprocessing Revenue by Type (2016-2021) & (USD Million)
Table 66. Asia-Pacific Cell Therapy Bioprocessing Revenue by Type (2021-2026) & (USD Million)
Table 67. Asia-Pacific Cell Therapy Bioprocessing Revenue by Application (2016-2021) & (USD Million)
Table 68. Asia-Pacific Cell Therapy Bioprocessing Revenue by Application (2021-2026) & (USD Million)
Table 69. Asia-Pacific Cell Therapy Bioprocessing Revenue by Region (2016-2021) & (USD Million)
Table 70. Asia-Pacific Cell Therapy Bioprocessing Revenue by Region (2021-2026) & (USD Million)
Table 71. South America Cell Therapy Bioprocessing Revenue by Type (2016-2021) & (USD Million)
Table 72. South America Cell Therapy Bioprocessing Revenue by Type (2021-2026) & (USD Million)
Table 73. South America Cell Therapy Bioprocessing Revenue by Application (2016-2021) & (USD Million)
Table 74. South America Cell Therapy Bioprocessing Revenue by Application (2021-2026) & (USD Million)
Table 75. South America Cell Therapy Bioprocessing Revenue by Country (2016-2021) & (USD Million)
Table 76. South America Cell Therapy Bioprocessing Revenue by Country (2021-2026) & (USD Million)
Table 77. Middle East & Africa Cell Therapy Bioprocessing Revenue by Type (2016-2021) & (USD Million)
Table 78. Middle East & Africa Cell Therapy Bioprocessing Revenue by Type (2021-2026) & (USD Million)
Table 79. Middle East & Africa Cell Therapy Bioprocessing Revenue by Application (2016-2021) & (USD Million)
Table 80. Middle East & Africa Cell Therapy Bioprocessing Revenue by Application (2021-2026) & (USD Million)
Table 81. Middle East & Africa Cell Therapy Bioprocessing Revenue by Country (2016-2021) & (USD Million)
Table 82. Middle East & Africa Cell Therapy Bioprocessing Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Cell Therapy Bioprocessing Picture
Figure 2. Global Cell Therapy Bioprocessing Revenue Market Share by Type in 2020
Figure 3. Immune Cell
Figure 4. Human Embryonic Stem Cells
Figure 5. Pluripotent Stem Cells Stem Cell
Figure 6. Hematopoetic Stem Cells
Figure 7. Cell Therapy Bioprocessing Revenue Market Share by Application in 2020
Figure 8. Cardiovascular Disease (CVD) Picture
Figure 9. Oncology Picture
Figure 10. Wound Healing Picture
Figure 11. Orthopedic Picture
Figure 12. Others Picture
Figure 13. Global Cell Therapy Bioprocessing Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Cell Therapy Bioprocessing Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Cell Therapy Bioprocessing Revenue Market Share by Region (2016-2026)
Figure 16. Global Cell Therapy Bioprocessing Revenue Market Share by Region in 2020
Figure 17. North America Cell Therapy Bioprocessing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Cell Therapy Bioprocessing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Cell Therapy Bioprocessing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Cell Therapy Bioprocessing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Cell Therapy Bioprocessing Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Cell Therapy Bioprocessing Market Drivers
Figure 23. Cell Therapy Bioprocessing Market Restraints
Figure 24. Cell Therapy Bioprocessing Market Trends
Figure 25. Fresenius Medical Care Recent Developments and Future Plans
Figure 26. Omnica Corporation Recent Developments and Future Plans
Figure 27. Medtronic Recent Developments and Future Plans
Figure 28. Baxter International Recent Developments and Future Plans
Figure 29. B. Braun Recent Developments and Future Plans
Figure 30. Nikkiso Recent Developments and Future Plans
Figure 31. Asahi Kasei Medical Recent Developments and Future Plans
Figure 32. Infomed Recent Developments and Future Plans
Figure 33. Bellco Recent Developments and Future Plans
Figure 34. Global Cell Therapy Bioprocessing Revenue Share by Players in 2020
Figure 35. Cell Therapy Bioprocessing Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 36. Global Top 3 Players Cell Therapy Bioprocessing Revenue Market Share in 2020
Figure 37. Global Top 10 Players Cell Therapy Bioprocessing Revenue Market Share in 2020
Figure 38. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 39. Global Cell Therapy Bioprocessing Revenue Share by Type in 2020
Figure 40. Global Cell Therapy Bioprocessing Market Share Forecast by Type (2021-2026)
Figure 41. Global Cell Therapy Bioprocessing Revenue Share by Application in 2020
Figure 42. Global Cell Therapy Bioprocessing Market Share Forecast by Application (2021-2026)
Figure 43. North America Cell Therapy Bioprocessing Sales Market Share by Type (2016-2026)
Figure 44. North America Cell Therapy Bioprocessing Sales Market Share by Application (2016-2026)
Figure 45. North America Cell Therapy Bioprocessing Revenue Market Share by Country (2016-2026)
Figure 46. United States Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Canada Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Mexico Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. Europe Cell Therapy Bioprocessing Sales Market Share by Type (2016-2026)
Figure 50. Europe Cell Therapy Bioprocessing Sales Market Share by Application (2016-2026)
Figure 51. Europe Cell Therapy Bioprocessing Revenue Market Share by Country (2016-2026)
Figure 52. Germany Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. France Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. United Kingdom Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Russia Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Italy Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Asia-Pacific Cell Therapy Bioprocessing Sales Market Share by Type (2016-2026)
Figure 58. Asia-Pacific Cell Therapy Bioprocessing Sales Market Share by Application (2016-2026)
Figure 59. Asia-Pacific Cell Therapy Bioprocessing Revenue Market Share by Region (2016-2026)
Figure 60. China Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Japan Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South Korea Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. India Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Southeast Asia Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. Australia Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 66. South America Cell Therapy Bioprocessing Sales Market Share by Type (2016-2026)
Figure 67. South America Cell Therapy Bioprocessing Sales Market Share by Application (2016-2026)
Figure 68. South America Cell Therapy Bioprocessing Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East and Africa Cell Therapy Bioprocessing Sales Market Share by Type (2016-2026)
Figure 72. Middle East and Africa Cell Therapy Bioprocessing Sales Market Share by Application (2016-2026)
Figure 73. Middle East and Africa Cell Therapy Bioprocessing Revenue Market Share by Country (2016-2026)
Figure 74. Turkey Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. UAE Cell Therapy Bioprocessing Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Methodology
Figure 78. Research Process and Data Source